Fortrea (NASDAQ:FTRE) Price Target Raised to $26.00 at Truist Financial

Fortrea (NASDAQ:FTRE) had its price objective hoisted by stock analysts at Truist Financial from $19.00 to $26.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price target would indicate a potential upside of 33.94% from the stock’s current price.

FTRE has been the topic of several other reports. Mizuho boosted their price objective on Fortrea from $13.00 to $16.00 and gave the stock a “neutral” rating in a research note on Monday, July 13th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $20.00 target price on shares of Fortrea in a report on Thursday. Citigroup boosted their target price on Fortrea from $16.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Weiss Ratings restated a “sell (d-)” rating on shares of Fortrea in a report on Friday, July 17th. Finally, Evercore restated an “outperform” rating on shares of Fortrea in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $19.75.

Fortrea Price Performance

FTRE stock traded down $0.99 during trading on Thursday, hitting $19.41. 407,523 shares of the company’s stock traded hands, compared to its average volume of 1,507,441. Fortrea has a 52 week low of $5.26 and a 52 week high of $21.39. The company has a debt-to-equity ratio of 1.98, a quick ratio of 0.95 and a current ratio of 0.95. The business has a fifty day simple moving average of $16.81 and a 200 day simple moving average of $13.79. The stock has a market capitalization of $1.84 billion, a price-to-earnings ratio of -3.96, a P/E/G ratio of 0.63 and a beta of 2.03.

Fortrea (NASDAQ:FTRE) last posted its earnings results on Wednesday, July 29th. The company reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $678.20 million for the quarter, compared to the consensus estimate of $647.57 million. Fortrea had a negative net margin of 16.50% and a positive return on equity of 9.51%. As a group, research analysts expect that Fortrea will post 0.8 EPS for the current fiscal year.

Institutional Trading of Fortrea

Institutional investors and hedge funds have recently made changes to their positions in the business. Larson Financial Group LLC boosted its stake in shares of Fortrea by 136.7% during the fourth quarter. Larson Financial Group LLC now owns 1,856 shares of the company’s stock valued at $32,000 after purchasing an additional 1,072 shares during the period. Toronto Dominion Bank purchased a new position in Fortrea in the 4th quarter worth about $51,000. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Fortrea by 27.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,490 shares of the company’s stock valued at $77,000 after buying an additional 980 shares in the last quarter. Osaic Holdings Inc. increased its position in shares of Fortrea by 74.3% during the second quarter. Osaic Holdings Inc. now owns 6,844 shares of the company’s stock worth $38,000 after acquiring an additional 2,918 shares during the period. Finally, Public Employees Retirement System of Ohio increased its position in shares of Fortrea by 37.9% during the third quarter. Public Employees Retirement System of Ohio now owns 8,386 shares of the company’s stock worth $71,000 after acquiring an additional 2,303 shares during the period.

Fortrea News Roundup

Here are the key news stories impacting Fortrea this week:

• Positive Sentiment: Fortrea reported second-quarter earnings of $0.23 per share, exceeding the $0.18 analyst consensus and improving from $0.19 a year earlier. Revenue reached $678.2 million, above the $647.6 million estimate. Fortrea Surpasses Q2 Earnings and Revenue Estimates
• Positive Sentiment: Management raised or increased its full-year outlook, forecasting 2026 revenue of $2.62 billion to $2.69 billion. The company highlighted four consecutive quarters of commercial, operational and financial execution, supporting investor confidence in its turnaround. Fortrea Reports Second Quarter 2026 Results
• Positive Sentiment: The earnings call commentary characterized the full-year sales outlook as optimistic and emphasized continued execution, which may reinforce expectations for improving profitability. Fortrea Reports Strong Q2 and Optimistic Guidance

About Fortrea

Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific’s Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company’s comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.

Fortrea’s core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.